Join, Follow & Connect
Join Modern Healthcare's LinkedIn group Follow Modern Healthcare on Twitter Join Modern Healthcare's Facebook group Follow Modern Healthcare's Pinterest board Modern Healthcare's Flickr page Modern Healthcare's YouTube Channel Get a Modern Healthcare news feed

 
Comment Buy Reprints Print Article Share on LinkedIn Share on Facebook Share on Twitter Email this page to a colleague
Healthcare Business News
 

McKesson sees profit drop 79% in Q3


By Rachel Landen
Posted: January 31, 2014 - 6:45 am ET
Tags:

McKesson Corp.'s earnings took a 79% dive in its third quarter despite revenue growth across the company's segments.

Revenue for the San Francisco-based pharmaceutical distributor and information technology company were $34.3 billion for the period ended Dec. 31, up 10% from $31.1 billion a year ago. But operational gains were offset by charges related to inventory adjustments, restructuring, and an ongoing transfer pricing dispute with the Canada Revenue Agency.

Advertisement | View Media Kit

 

Those expenses cut into McKesson's third quarter profits, resulting in net income of $64 million for the period, down from $298 million a year earlier. But in a call with analysts, McKesson Chairman and CEO John Hammergren said he was pleased with both the results of the company's distribution solutions segment—where adjusted operating profit grew by 37%—and especially with last week's announcement of McKesson's acquisition of German rival Celesio.

In buying Celesio shares and convertible bonds, McKesson was able to secure more than the 75% ownership stake needed to purchase the company. Once that transaction closes Feb. 6, McKesson plans to launch a tender offer for the remaining outstanding shares and will begin to consolidate financial results during its fourth quarter. However, McKesson Executive VP and CFO James Beer told analysts during the call that the acquisition is not expected to have a “meaningful impact” on fourth quarter results.

With this latest release, McKesson updated its full fiscal year earnings guidance. The company expects adjusted earnings per diluted share will fall between $8.05 to $8.20. That's down from a previous estimate of $8.40 to $8.70 per share.


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.